Literature DB >> 11952637

Yersinia effectors target mammalian signalling pathways.

Stephen J Juris1, Feng Shao, Jack E Dixon.   

Abstract

Animals have an immune system to fight off challenges from both viruses and bacteria. The first line of defence is innate immunity, which is composed of cells that engulf pathogens as well as cells that release potent signalling molecules to activate an inflammatory response and the adaptive immune system. Pathogenic bacteria have evolved a set of weapons, or effectors, to ensure survival in the host. Yersinia spp. use a type III secretion system to translocate these effector proteins, called Yops, into the host. This report outlines how Yops thwart the signalling machinery of the host immune system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11952637     DOI: 10.1046/j.1462-5822.2002.00182.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  25 in total

1.  Biochemical characterization of the Yersinia YopT protease: cleavage site and recognition elements in Rho GTPases.

Authors:  Feng Shao; Panayiotis O Vacratsis; Zhaoqin Bao; Katherine E Bowers; Carol A Fierke; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

2.  The C terminus of YopT is crucial for activity and the N terminus is crucial for substrate binding.

Authors:  Isabel Sorg; Claudia Hoffmann; Juergen Dumbach; Klaus Aktories; Gudula Schmidt
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

3.  A Pseudomonas syringae type III effector suppresses cell wall-based extracellular defense in susceptible Arabidopsis plants.

Authors:  Paula Hauck; Roger Thilmony; Sheng Yang He
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-19       Impact factor: 11.205

4.  The Yersinia enterocolitica effector YopP inhibits host cell signalling by inactivating the protein kinase TAK1 in the IL-1 signalling pathway.

Authors:  Axel Thiefes; Alexander Wolf; Anneke Doerrie; Guntram A Grassl; Kunihiro Matsumoto; Ingo Autenrieth; Erwin Bohn; Hiroaki Sakurai; Rainer Niedenthal; Klaus Resch; Michael Kracht
Journal:  EMBO Rep       Date:  2006-07-14       Impact factor: 8.807

5.  Downregulation of mitogen-activated protein kinases by the Bordetella bronchiseptica Type III secretion system leads to attenuated nonclassical macrophage activation.

Authors:  Annette Reissinger; Jason A Skinner; Ming H Yuk
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 6.  Interaction between Yersinia pestis and the host immune system.

Authors:  Bei Li; Ruifu Yang
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

7.  Yersinia enterocolitica inhibits Salmonella enterica serovar Typhimurium and Listeria monocytogenes cellular uptake.

Authors:  Fabien Habyarimana; Matthew C Swearingen; Glenn M Young; Stephanie Seveau; Brian M M Ahmer
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

8.  Early evolutionary loss of the lipid A modifying enzyme PagP resulting in innate immune evasion in Yersinia pestis.

Authors:  Courtney E Chandler; Erin M Harberts; Mark R Pelletier; Iyarit Thaipisuttikul; Jace W Jones; Adeline M Hajjar; Jason W Sahl; David R Goodlett; Aaron C Pride; David A Rasko; M Stephen Trent; Russell E Bishop; Robert K Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-31       Impact factor: 11.205

9.  The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence.

Authors:  Jens P Grabenstein; Michael Marceau; Céline Pujol; Michel Simonet; James B Bliska
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  Genomic characterization of the Yersinia genus.

Authors:  Peter E Chen; Christopher Cook; Andrew C Stewart; Niranjan Nagarajan; Dan D Sommer; Mihai Pop; Brendan Thomason; Maureen P Kiley Thomason; Shannon Lentz; Nichole Nolan; Shanmuga Sozhamannan; Alexander Sulakvelidze; Alfred Mateczun; Lei Du; Michael E Zwick; Timothy D Read
Journal:  Genome Biol       Date:  2010-01-04       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.